As reported, AA and its downstream metabolite prostaglandin E2 (PGE2) could modulate tumor microenvironment, and promote carcinogenesis and angiogenesis by activating PI3K-AKT signaling and mTOR signaling14–17. The gene discussed is MTOR; the disease is neoplasm.